Avaí Bio, Inc.
AVAI
$0.33
-$0.02-4.68%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.74% | -49.15% | -32.58% | -28.61% | -7.25% |
| Depreciation & Amortization | -66.64% | -50.00% | -29.86% | -3.51% | 215.82% |
| Other Operating Expenses | -1,026.07% | -3,089.57% | -1,864.04% | -3,557.52% | 208.85% |
| Total Operating Expenses | -45.99% | -62.38% | -51.07% | -46.44% | -2.17% |
| Operating Income | 45.99% | 62.38% | 51.07% | 46.44% | 2.17% |
| Income Before Tax | 45.99% | 62.38% | 51.07% | 46.44% | 2.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.99% | 62.38% | 51.07% | 46.44% | 2.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.99% | 62.38% | 51.07% | 46.44% | 2.17% |
| EBIT | 45.99% | 62.38% | 51.07% | 46.44% | 2.17% |
| EBITDA | 45.24% | 63.24% | 52.32% | 48.46% | 5.98% |
| EPS Basic | 50.67% | 73.41% | 67.19% | 66.19% | 46.81% |
| Normalized Basic EPS | 50.53% | 72.96% | 66.46% | 65.54% | 46.63% |
| EPS Diluted | 50.67% | 73.41% | 67.19% | 66.19% | 46.81% |
| Normalized Diluted EPS | 50.53% | 72.96% | 66.46% | 65.54% | 46.63% |
| Average Basic Shares Outstanding | 5.53% | 19.60% | 30.57% | 46.03% | 97.42% |
| Average Diluted Shares Outstanding | 5.53% | 19.60% | 30.57% | 46.03% | 97.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |